WeVote

Bill

Bill

SB 422

Generally revise laws relating to insurance coverage relating to cancer

2025 Regular Session Introduced by Ellie Boldman

Montana bill expands mandated insurance coverage for cancer-related treatments, vetoed by governor; legislature's override vote failed to gain necessary support.

(S) Veto Override Failed in Legislature
0
WeVote Research Nonpartisan
Bill Summary · SB 422

Legislative bill overview

SB 422 revises Montana insurance laws to expand coverage requirements and protections for cancer-related treatments and services. The bill modifies existing insurance regulations to mandate certain cancer care benefits that insurers must provide to policyholders. Specific provisions likely address coverage gaps for preventive screening, treatment options, or supportive care services related to cancer diagnosis and management.

Why is this important

Cancer treatment is one of the most expensive medical conditions, and insurance coverage gaps can make care unaffordable or inaccessible for many Montanans. Mandating broader insurance coverage affects both patient access to potentially life-saving treatments and healthcare costs for insurers, which may influence premium pricing. The bill's veto and failed override suggest significant disagreement between the legislature and governor over the proper scope of insurance regulation and its economic implications.

Potential points of contention

  • Cost implications: Expanded cancer coverage mandates increase insurer costs, which typically get passed to consumers through higher premiums, potentially affecting affordability for those without cancer diagnoses
  • Scope of mandates: Disagreement over which cancer-related treatments (experimental drugs, alternative therapies, etc.) should be mandatory versus discretionary insurance decisions
  • Regulatory approach: Whether the state should mandate specific insurance benefits or allow market competition and individual policy choices to determine coverage options

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.